INS and type 2 diabetes mellitus: In particular, these studies described the impact of the MTNR1B (melatonin receptor 1B) polymorphism on fasting glucose or insulin-secretion-related traits and on T2D risk [135,136,137,138], which might be explained by the impact of melatonin signaling on insulin secretion [139].